167 related articles for article (PubMed ID: 15274676)
1. Efficacy and safety of DALI-LDL-apheresis in two patients treated with the angiotensin II-receptor 1 antagonist losartan.
Bosch T; Wendler T
Ther Apher Dial; 2004 Aug; 8(4):269-74. PubMed ID: 15274676
[TBL] [Abstract][Full Text] [Related]
2. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
4. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
Bosch T
Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
[TBL] [Abstract][Full Text] [Related]
5. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
6. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
7. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
[TBL] [Abstract][Full Text] [Related]
8. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
9. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
Otto C; Berster J; Otto B; Parhofer KG
J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
[TBL] [Abstract][Full Text] [Related]
10. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.
Bosch T; Lennertz A; Kordes B; Samtleben W
Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617
[TBL] [Abstract][Full Text] [Related]
12. Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility.
Wendler T; Lennertz A; Heinemann O; Duhr C; Samtleben W; Bosch T
Int J Artif Organs; 2000 Oct; 23(10):710-7. PubMed ID: 11075902
[TBL] [Abstract][Full Text] [Related]
13. Effect of different LDL-apheresis methods on parameters involved in atherosclerosis.
Hershcovici T; Schechner V; Orlin J; Harell D; Beigel Y
J Clin Apher; 2004; 19(2):90-7. PubMed ID: 15274202
[TBL] [Abstract][Full Text] [Related]
14. Modified DALI LDL-apheresis using trisodium citrate anticoagulation plus bicarbonate or lactate-buffered hemofiltration substitution fluids as primers.
Bosch T; Wendler T; Maschke H
Artif Organs; 2003 Jun; 27(6):555-64. PubMed ID: 12780510
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report.
Bosch T; Lennertz A; Samtleben W
Ther Apher; 2001 Oct; 5(5):358-63. PubMed ID: 11778920
[TBL] [Abstract][Full Text] [Related]
16. LDL apheresis: a novel technique (LIPOCOLLECT 200).
Stefanutti C; Di Giacomo S; Mazzarella B; Castelli A
Artif Organs; 2009 Dec; 33(12):1103-8. PubMed ID: 19995360
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial.
Bosch T; Heinemann O; Duhr C; Wendler T; Keller C; Fink E; Kirschner T; Klebert S; Samtleben W
Artif Organs; 2000 Oct; 24(10):790-6. PubMed ID: 11091168
[TBL] [Abstract][Full Text] [Related]
19. Contact activation in low-density lipoprotein apheresis systems.
Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
[TBL] [Abstract][Full Text] [Related]
20. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.
Bosch T; Schmidt B; Kleophas W; Gillen C; Otto V; Passlick-Deetjen J; Gurland HJ
Artif Organs; 1997 Sep; 21(9):977-82. PubMed ID: 9288867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
